Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome

Pediatric Nephrology

Volumn 22, Issue 12, 2007, Pages 2059-2065

  Afzal, Kamran ^a   Bagga, Arvind ^a   Menon, Shina ^a   Hari, Pankaj ^a   Jordan, Stanley C ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Focal segmental glomerulosclerosis; Frequent relapses; Minimal change disease; Prednisolone

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; LEVAMISOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RANITIDINE;

ABDOMINAL PAIN; ARTICLE; BEHAVIOR DISORDER; CATARACT; CELLULITIS; CHILD; CHILD HEALTH; CLINICAL ARTICLE; CUSHINGOID SYNDROME; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; HEMATOLOGIC DISEASE; HEPATITIS A; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LEUKOPENIA; LONG TERM CARE; MOLLUSCUM CONTAGIOSUM; MULTIPLE CYCLE TREATMENT; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERITONITIS; PRIORITY JOURNAL; RELAPSE; REMISSION; STEROID DEPENDENT NEPHROTIC SYNDROME; STRIA; THROMBOCYTOPENIA; VOMITING;

CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MALE; MYCOPHENOLIC ACID; NEPHROTIC SYNDROME; PREDNISOLONE; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 36049010010     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0617-9     Document Type: Article

References (22)

1. Thorban S, Schwarznau A, Huser N, Stangl M (2006) Efficacy of conventional immunosuppressive therapy in related and unrelated living renal transplantation. Clin Transplant 20:284-288
2. Pisoni CN, Karim Y, Cuadrado MJ (2005) Mycophenolate mofetil and systemic lupus erythematosus: An overview. Lupus 14 (Suppl 1):S9-S11
3. D'Cruz DP (2005) Mycophenolate mofetil in systemic vasculitis. Lupus 14 (Suppl 1):S55-S57
4. Frisch G, Lin J, Rosenstock J, Markowitz G, D'Agati V, Radhakrishnan J, Preddie D, Crew J, Valeri A, Appel G (2005) Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: A double blind randomized controlled trial. Nephrol Dial Transplant 20:2139-2145
5. Cattran DC (2003) Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy. Semin Nephrol 23:272-277
6. Bagga A, Mantan M (2005) Nephrotic syndrome in children. Indian J Med Res 122:13-28
7. Mendizabal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J (2005) Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Pediatr Nephrol 20:914-919
8. Moudgil A, Bagga A, Jordan SC (2005) Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: Current status and future directions. Pediatr Nephrol 20:1376-1381
9. Hogg RJ, Fitzgibbons L, Bruick J, Bunke M, Ault B, Baqi N, Trachtman H, Swinford R (2006) Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: A report from the Southwest Pediatric Nephrology Study Group. Clin J Am Soc Nephrol 1:1173-1178
10. Gellermann J, Querfeld U (2004) Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatr Nephrol 19:101-104
11. Bagga A, Hari P, Moudgil A, Jordan SC (2003) Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis 42:1114-1120
12. Indian Pediatric Nephrology Group, Indian Academy of Pediatrics (2001) Consensus statement on management of steroid sensitive nephrotic syndrome. Indian Pediatr 38:975-986
13. Bagga A, Hari P, Srivastava RN (1999) Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome. Pediatr Nephrol 13:824-827
14. Bagga A, Sharma A, Srivastava RN (1997) Levamisole therapy in corticosteroid-dependent nephrotic syndrome. Pediatr Nephrol 11:415-417
15. Centers for Disease Control and Prevention, National Center for Health Statistics. CDC growth charts: United States http://www.cdc.gov/ growthcharts/ May 30, 2000
16. Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K (2007) A prospective study on the use of MMF in children with cyclosporine dependent nephrotic syndrome. Pediatr Nephrol 22:71-76
17. Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB (2003) Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol 18:833-837
18. Morath C, Schwenger V, Beimler J, Mehrabi A, Schmidt J, Zeier M, Muranyi W (2006) Antifibrotic actions of mycophenolic acid. Clin Transplant 20 (Suppl 17):25-29
19. Al-Akash S, Al-Makdama A (2005) Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome. Ann Saudi Med 25:380-384
20. Novak I, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H (2005) Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 20:1265-1268
21. Dorresteijn E, Kist-van Holthe J, Levtchenko E, Nauta J, Hop W, Van der Hejden A (2007) Randomized controlled trial of mycophenolate mofetil versus cyclosporine A in children with frequently relapsing nephrotic syndrome. Pediatr Nephrol 22:1442 (28 FC)
22. Jeong H, Kaplan B (2007) Therapeutic monitoring of mycophenolate mofetil. Clin J Am Soc Nephrol 2:184-191